Investment

Rhythm Biosciences Cancer Diagnostics Technology Advancement

Rhythm Biosciences Limited (ASX: RHY) is an Australian bioscience company specialising in early cancer detection and risk assessment through its innovative diagnostic tool. Two signature tools, ColoSTAT and geneType, are the flagship products, offering patients alternatives in the market to choose from. Rhythm Biosciences Limited was listed on ASX on 7 December 2017 at an […]

1st April 2025
Investment

Rhythm Biosciences Records First Commercial Sales from Genetype

20th March 2025

REACH YOUR FULL POTENTIAL

Ready to elevate yourgame to new heights? Look no further!

By submitting your details below, you’ll gain exclusive access to the finest content in investment and lifestyle from KODARI Magazine. Whether you’re seeking insights into luxury living, expert investment insights, or the latest trends in high-end fashion and travel, we’ve got you covered.